The Mechanism of Ciliary Stimulation by Acetylcholine: Roles of Calcium, PKA, and PKG by Zagoory, Orna et al.
 
329
 
J. Gen. Physiol.
 
 © The Rockefeller University Press 
 
•
 
 0022-1295/2002/04/329/11 $5.00
Volume 119 April 2002 329–339
http://www.jgp.org/cgi/content/full/119/4/329
 
The Mechanism of Ciliary Stimulation by Acetylcholine: Roles of 
Calcium, PKA, and PKG
 
Orna Zagoory, Alex Braiman, 
 
and
 
 Zvi Priel
 
Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
 
abstract
 
Stimulation of ciliary cells through muscarinic receptors leads to a strong biphasic enhancement of
ciliary beat frequency (CBF). The main goal of this work is to delineate the chain of molecular events that lead to
 
the enhancement of CBF induced by acetylcholine (ACh). Here we show that the Ca
 
2
 
 
 
, cGMP, and cAMP signal-
ing pathways are intimately interconnected in the process of cholinergic ciliary stimulation. ACh induces pro-
found time-dependent increase in cGMP and cAMP concentrations mediated by the calcium–calmodulin com-
plex. The initial strong CBF enhancement in response to ACh is mainly governed by PKG and elevated calcium.
The second phase of CBF enhancement induced by ACh, a stable moderately elevated CBF, is mainly regulated by
PKA in a Ca
 
2
 
 
 
-independent manner. Inhibition of either guanylate cyclase or of PKG partially attenuates the re-
sponse to ACh of [Ca
 
2
 
 
 
]
 
i
 
, but completely abolishes the response of CBF. Inhibition of PKA moderately attenuates
and signiﬁcantly shortens the responses to ACh of both [Ca
 
2
 
 
 
]
 
i
 
 and CBF. In addition, PKA facilitates the elevation
in [Ca
 
2
 
 
 
]
 
i
 
 and cGMP levels induced by ACh, whereas an unimpeded PKG activity is essential for CBF enhance-
ment mediated by either Ca
 
2
 
 
 
 or PKA.
 
key words:
 
cilia • mucociliary tissue • phosphorylation • cholinergic • cyclic nucleotides
 
INTRODUCTION
 
The primary task of mucociliary system is to propel a
mucus blanket containing various materials and parti-
cles over the epithelial tissues (Sade et al., 1970; Sleigh,
1982; Sleigh et al., 1988). Highly cooperative beating of
cilia (Gheber and Priel, 1989, 1994) at high frequen-
cies enables the mucociliary system to carry relatively
large objects, at remarkable velocities. However, the
payment for high frequency beating is a loss of an ap-
preciable amount of energy by the ciliary cell. There-
fore, under normal conditions, cilia beat at a low fre-
quency. However, they can dramatically change their
activity in response to a variety of receptor-mediated
stimuli. In many mucociliary systems ciliary beat fre-
quency (CBF),* is stimulated via purinergic P2 (Var-
haus and Deyrup, 1953; Ovadyahu et al., 1988; Villalon
et al., 1989; Mason et al., 1991; Wong and Yeates, 1992;
Gheber et al., 1995; Korngreen and Priel, 1996;
Braiman et al., 2000a) or cholinergic receptors (Aiello
et al., 1991; Salathe et al., 1997; Zagoory et al., 2001).
 
Three ubiquitous second messengers (Ca
 
2
 
 
 
, cGMP,
and cAMP) have been shown to participate in the pro-
cess of ciliary stimulation (Verdugo, 1980; Tamaoki et
al., 1989; Di Benedetto et al., 1991a,b; Lansley et al.,
1992; Korngreen and Priel, 1994; Geary et al., 1995;
Salathe and Bookman, 1995; Yang et al., 1996; Runer et
al., 1998). It has become an accepted view that each of
these messengers represents an independent pathway,
which leads to the CBF enhancement. However, our re-
cent work seriously undermines this conception. Inhi-
bition of the nitric oxide-cGMP-PKG signaling pathway
at any of its stages abolished the CBF enhancement in
the presence of high intracellular calcium concentra-
tion ([Ca
 
2
 
 
 
]
 
i
 
; Uzlaner and Priel, 1999; Braiman et al.,
 
2000b). It is well-known that the calcium–calmodu-
lin complex (Ca-CaM) activates nitric oxide (Stuehr,
1999). Indeed, inhibition of calmodulin nulliﬁed cili-
ary beat frequency enhancement in the presence of
high [Ca
 
2
 
 
 
]
 
i 
 
(Braiman et al., 2000b). These ﬁndings
demonstrate that elevated [Ca
 
2
 
 
 
]
 
i
 
 itself, without partici-
pation of PKG, cannot enhance CBF.
 
Recently, a study has been conducted aiming to inves-
tigate the effect of acetylcholine (ACh) on the tissue cul-
tures from frog esophagus (Zagoory et al., 2001). It has
been found that ACh induces a profound increase in
 
CBF and [Ca
 
2
 
 
 
]
 
i
 
 through M1 and M3 muscarinic recep-
tors; that the response in CBF is mediated by PLC and
calmodulin (CaM); that the rise in [Ca
 
2
 
 
 
]
 
i
 
 is achieved
solely through calcium mobilization from the intracellu-
lar stores; and that the time course of the CBF enhance-
ment exhibited a clear biphasic pattern. The ﬁrst phase
 
of the response, which lasted 
 
 
 
3–6 min, was character-
ized by a well correlated change in both CBF and
[Ca
 
2
 
 
 
]
 
i
 
, consisting of a rapid increase followed by a grad-
ual decay. However, in the course of the decay, the corre-
lation between [Ca
 
2
 
 
 
]
 
i
 
 and CBF had been gradually lost,
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indicating transition into the second phase of the re-
sponse. During this phase, [Ca
 
2
 
 
 
]
 
i
 
 declined to its basal
level, whereas CBF stabilized at a moderately excited
state (between 50 and 100% above the basal level). Fi-
nally, inhibition of calmodulin moderately attenuated
the response of [Ca
 
2
 
 
 
]
 
i
 
, but abolished completely both
the ﬁrst and the second phase of the CBF enhancement.
That was a surprising result due to the fact that the sec-
ond phase was apparently independent of [Ca
 
2
 
 
 
]
 
i
 
.
These ﬁndings strongly suggested that the molecular
events underlying the CBF stimulation by ACh com-
bined into a complex mechanism, involving several in-
teracting signaling pathways. The aim of this work is to
delineate the chain of events that lead to the biphasic
enhancement of CBF induced by ACh.
 
MATERIALS AND METHODS
 
Tissue Culture Preparation
 
Experiments were performed on monolayer tissue culture grown
from frog esophagus and palate of locally supplied frogs (
 
Rana
ridibunda
 
) using a procedure described previously (Eshel et al.,
1985). Brieﬂy, frogs were killed according to the guidelines laid
down by the animal welfare committee of Ben-Gurion University.
The esophagus or palate were removed from frogs and washed
three times in sterile medium. The epithelia were minced in cul-
ture medium (15% FCS, 64% L-15 Leibovitz medium, and 20%
sterile distilled water supplemented with antibiotics at a 1:10 dilu-
tion). Two to four tissue pieces were placed on plastic Petri
dishes (35 mm; Nunc) and overlaid with 0.7 ml of culture me-
dium. The culture medium was changed every 2 d and 5–21-
d-old tissue cultures were used for measurements. According to
Chu and Kennedy (1994), the muscarinic receptors on the mem-
brane of ciliated cells apparently are not lost during culture, and
can be maintained throughout the 3-wk culture period.
 
Chemicals and Solutions
 
The simultaneous measurements of [Ca
 
2
 
 
 
]
 
i
 
 and CBF were per-
formed in Ringer’s solution containing the following (in mM): 120
NaCl, 2.5 KCl, 1.8 CaCl
 
2
 
, 1.8 MgCl
 
2
 
, 5 HEPES, and 0.5 probenecid.
Solutions with low calcium concentration were prepared by
adding to Ca
 
2
 
 
 
-free Ringer’s solution 0.5 mM EGTA, 1.8 mM
Mg
 
2
 
 
 
, and a Ca
 
2
 
 
 
 in concentration calculated, according to
known equilibrium constants, to reach the desired free Ca
 
2
 
 
 
 con-
centration. The external calibration solution for fura-2 was com-
posed of the following (in mM): 115 KCl, 20 NaCl, 5 MgCl
 
2
 
, 5
 
d
 
-glucose, 5 HEPES, and 10 EGTA, and 1 
 
 
 
M K
 
5
 
Fura-2. All the
solutions were adjusted to pH
 
 
 
7.2–7.4 before use.
Ionomycin and KT8353 were dissolved in ethanol and H-89
was dissolved in the ethanol/water 1:1 mixture as concentrated
stock solutions and diluted into Ringer’s solution just before use.
The ﬁnal concentration of ethanol in the assay solution did not
exceed 0.5%. Thapsigargin was dissolved in DMSO as a concen-
trated stock solution. The ﬁnal concentration of DMSO in the as-
say solution did not exceed 0.05%.
HEPES, DMSO, EGTA, thapsigargin, and W-7 were obtained
from Sigma-Aldrich. Acetylcholine chloride, KCl, NaCl, MnCl
 
2
 
,
CaCl
 
2
 
, were obtained from Merck. Ionomycin was obtained from
Calbiochem; fura-2/AM was obtained either from Molecular
Probes or from Teﬂabs. K
 
5
 
Fura-2 and pluronic F-127 were pur-
chased from Molecular Probes. All tissue culture media and sup-
plements were supplied by Biological Industries.
 
Simultaneous Measurement of Intracellular Calcium and 
Ciliary Beating
 
Simultaneous measurements of intracellular calcium and ciliary
beating were performed as previously described (Korngreen and
Priel, 1994). Brieﬂy, the cells were preloaded with fura-2 by incu-
bating the tissue in serum-free growth medium, containing 5 
 
 
 
M
fura-2/AM, 0.03% pluronic F-127 and 500 
 
 
 
M probenecid, for 60
min at 32
 
 
 
C in a rotating water bath, followed by washing in
Ringer’s solution for 30 min. Pluronic F-127 is a nonpolar poly-
meric detergent that increases solubility of hydrophobic fura-2/
AM in aqueous media. Probenecid, an inhibitor of membrane or-
ganic anion transporters, is used widely to prevent extrusion of
loaded fura-2 from the cells. The dye loaded cells were epi-illumi-
nated with light from a 75-W xenon lamp (Oriel Corp.) ﬁltered
through 340- and 380-nm interference ﬁlters (Oriel) mounted
on a four position rotating ﬁlter wheel. The ﬂuorescence, emit-
ted at 510 nm, was detected by a photon counting photomulti-
plier (model H3460–53; Hamamatsu). The 340/380 ﬂuores-
cence ratio, averaged over a period of 1 s, was stored in a com-
puter. CBF was measured by transilluminating the same ciliary
area with light at 600 nm (so as not to interfere with fura-2 ﬂuo-
rescence at 510 nm). Scattering of the 600-nm light from the
beating cilia created amplitude modulations that were detected
by a photomultiplier (model R2014; Hamamatsu).
A calibration curve of the calcium concentration was created
by titrating an external calibration solution with a solution of the
same composition containing 10 mM CaCl
 
2
 
 (Grynkiewicz et al.,
1985; Korngreen and Priel, 1994). To account for the difference
between the fura-2 ﬂuorescence signal in the intracellular me-
dium and in the calibration solution, the maximal and minimal
values of the 340/380 ﬂuorescence ratio were measured from the
cells. The maximal value was obtained by the addition of 5 
 
 
 
M
ionomycin to the cells, which resulted in ﬂooding the cells with
Ca
 
2
 
 
 
. The minimal value was obtained by the addition of ionomy-
cin to the cells in a zero-calcium medium. The calibration curve
was corrected according to the obtained results. The nonspeciﬁc
signal was estimated by the addition of ionomycin to the cells in
the presence of 1 mM Mn
 
2
 
 
 
, which leads to quenching of fura-2
ﬂuorescence (Grynkiewicz et al., 1985; Kao, 1994; Takahashi et
al., 1999). The calcium concentration was calculated directly
from the corrected calibration curve by interpolation using a ta-
ble look-up algorithm.
Before any treatment, Ringer’s solution over the tissue culture
was changed twice. The tissue was preincubated in a third
change of the Ringer’s solution for 15–30 min before the experi-
ment to prevent any transient effects on ciliary motility.
The basal ciliary beat frequency (F
 
o
 
) and [Ca
 
2
 
 
 
]
 
i
 
 level were
measured for 2–5 min in 900–950 
 
 
 
l of the appropriate solution.
The results of these measurements were taken as reference val-
ues. Then, 50–100 
 
 
 
l of solution containing the test substance
were added to reach the desired ﬁnal concentration. In our ear-
lier experiments, an alternative technique also was used: the solu-
tion was rapidly changed to the one containing the test substance
using a constant ﬂow perfusion system. Our experience indicates
that the pattern and the magnitude of the response in either
CBF or [Ca
 
2
 
 
 
]
 
i
 
 do not depend on the manner of substance addi-
tion (Korngreen and Priel, 1994, 1996; Levin et al., 1997; Korn-
green et al., 1998; Zagoory et al., 2001). The frequency (F) and
[Ca
 
2
 
 
 
]
 
i
 
 were monitored on the same ciliary cell for 10– 40 min.
All experiments were performed at 23 
 
 
 
 0.5
 
 
 
C. Beat frequency
enhancement was represented as the observed frequency nor-
malized to the reference frequency (F
 
o
 
), i.e., F/F
 
o
 
 
 
 
 
 frequency
enhancement. The intracellular calcium elevation was repre-
sented by the difference 
 
 
 
[Ca
 
2
 
 
 
]
 
i
 
 between the observed calcium
level and the reference level. The results were presented as an av- 
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erage 
 
  
 
SEM, with 
 
n
 
 
 
 
 
 number of experiments in parentheses.
Every experiment was performed using 5–97 tissue cultures
taken from at least two animals. Each tissue culture was used only
once. Since the results obtained from tissue cultures grown from
either frog esophagus or frog palate were virtually identical, they
were combined for the purpose of this presentation.
 
Quantitative Determination of Cyclic Nucleotides
 
The esophagus tissue was cut into four to six pieces (
 
 
 
30 mg
each). These pieces were placed in stimulation medium (Ringer’s
solution supplemented with the tested materials). Before any treat-
ment, Ringer’s solution over the tissue culture was changed twice.
The tissue was preincubated in a third change of the Ringer’s solu-
tion for 15–30 min before the experiment to prevent any transient
effects. The stimulation was stopped by freezing in liquid nitrogen.
To prevent build-up of an icy layer over the ciliary tissue, the thin
layer of liquid was absorbed off the tissue by lint-free paper before
freezing. The ciliary side of the frozen tissue was scrubbed three
times with a scalpel and cells were collected into 0.8 ml of 0.1 N
HCl. Cells were homogenized by grinding at 300 rpm for 40 s and
the homogenate was centrifuged. Two samples of 100 
 
 
 
l from the
supernatant were taken for the quantitative determination of cy-
clic nucleotide concentration.
Determination of the cyclic nucleotide concentration was
done by using a commercial kit: Correlate-EIA direct cyclic AMP
enzyme immunoassay kit, or Correlate-EIA direct cyclic GMP en-
zyme immunoassay kit. Brieﬂy, the method is based on ELISA, a
competitive immunoassay for the quantitative determination of
the relevant nucleotide in samples treated with 0.1 N HCl. Ac-
cording to the protocol supplied with the kit, the samples, as well
as the standards, underwent acetylation. Since the antibody bet-
ter recognizes the acetylated nucleotides, this procedure in-
creased the sensitivity of the analysis. The measurements were
done in duplicate. At the ﬁnal step, the optical density of samples
and standards were measured. The amount of the nucleotide in
each sample was calculated based on a standard curve. The pro-
tein concentration of the supernatant was determined by Bio-
Rad assay. It is important to note that the amount of the cyclic
nucleotides may vary with sex, age, and the seasons of the year.
For instance, during the winter time, the levels of cAMP were
very high (ﬁve times higher than in the spring). Due to those
variations, the concentrations of the cyclic nucleotides for each
experiment were presented as relative values normalized to the
levels obtained from the tissues subjected to the same treatment,
but without application of the stimulant.
The cross reactivities for cAMP or cGMP was determined by
Assay Designs, Inc. The cross reactivities of cGMP and cAMP
were 
 
 
 
0.05%, as determined by Correlate-EIA direct cAMP en-
zyme immunoassay kit and Correlate-EIA direct cGMP enzyme
immunoassay kit, respectively. The endogenous levels of cGMP
were near the low end of the kit sensitivity. Therefore, in the
cGMP detection experiments, the tissues were stimulated in the
presence of a phosphodiesterase inhibitor, IBMX (1 mM).
 
RESULTS
 
Acetylcholine Elevates the Endogenous Levels of 
cGMP and cAMP
 
Recently, we have reported that Ca-CaM plays a pivotal
role in CBF stimulation by ACh (Zagoory et al., 2001),
and it is well-known that Ca-CaM triggers a multitude of
cellular events, including activation of guanylate cy-
clase (GC) and adenylate cyclase (AC; Hinrichsen,
 
1993; Antoni, 1997; Stuehr, 1999; Chin and Means,
2000; Groves and Wang, 2000). Therefore, it is reason-
able to assume that ACh relies on the cGMP and cAMP
pathways to stimulate CBF.
We examined the ability of ACh to alter the cytosolic
levels of the cAMP and cGMP in the ciliary tissue from
frog esophagus. As can be seen (Fig. 1), 10 
 
 
 
M ACh el-
evated the cytosolic levels of cAMP or cGMP in a time
dependent manner. The time course of the elevation in
cGMP was characterized by a bell-shaped pattern. An
initial slight decrease in the cGMP levels was followed
by a steady elevation and the maximal response of a
4.50
 
   
 
1.3-fold increase was achieved in 4–5 min after
stimulation. Subsequently, the cytosolic level of cGMP
gradually declined, attaining its basal value at 
 
 
 
5 min
after reaching the maximum.
Figure 1. Effect of ACh on the intracellular levels of cGMP and
cAMP. The time course of the changes in the cGMP (A) and cAMP
(B) levels in the cells stimulated by 10  M ACh. The changes in
the levels of each nucleotide are shown as a normalized increase
relative to the levels of the same nucleotide obtained before appli-
cation of ACh. Each point represents an average over 2–14 experi-
ments with error bars representing the SEM. 
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In contrast to cGMP, the rate of cAMP accumulation
was considerably slower. The cytosolic level of cAMP
reached its maximum of a 3.58
 
    
 
1.2-fold increase
within 10 min after stimulation. Furthermore, after
reaching the maximum, the cAMP concentration was
relatively stable, remaining at the submaximal values
for at least another 5 min
 
Ca-CaM Mediates Activation of Guanylate Cyclase and 
Adenylate Cyclase
 
To assess the role of Ca-CaM in the elevation of the
cGMP and cAMP levels induced by ACh, several sets of
experiments were performed. First, the cells were
treated with a calmodulin inhibitor W-7 (150 
 
 
 
M;
Hidaka et al., 1981) for 10–13 min before application
of ACh. In the cells pretreated with the inhibitor, the
elevation in both cGMP and cAMP levels induced by
ACh was strongly attenuated, being 1.52
 
    
 
0.09-fold
and 1.22
 
   
 
0.16-fold, respectively (Fig. 2).
To deter the elevation in [Ca
 
2
 
 
 
]
 
i
 
 induced by ACh,
thereby preventing formation of Ca-CaM, the intracel-
lular calcium stores were depleted by a prolonged (50
min) incubation of the cells in the low [Ca
 
2
 
 
 
] medium
(1 
 
 
 
M). Alternatively, the cells were treated with thapsi-
gargin, an inhibitor of the store Ca
 
2
 
 
 
 pumps, for 50
min before application of ACh. Due to the inhibition
of the pumps, thapsigargin induces leakage of Ca
 
2
 
 
 
from the stores, accompanied by a transient rise in
[Ca
 
2
 
 
 
]
 
i
 
, and eventual depletion of the stores. To test
the viability of the cells during such prolonged experi-
ments, CBF was monitored under the same experimen-
tal conditions. In the cells exposed to the micromolar
range of extracellular [Ca
 
2
 
 
 
] or treated with thapsigar-
gin, the CBF returned to its basal value within 30–40
min after initiation of the treatment and continued to
beat at this frequency until the experiment was termi-
nated (additional 30 min). As can be seen (Fig. 2), the
depletion of the stores achieved by either of these treat-
ments inhibited the ACh-induced elevation in cGMP
and cAMP levels with the same efﬁcacy as application of
the CaM inhibitor. The conclusion is that calcium ions
are essential for the elevation of cAMP or cGMP levels
by ACh. Most probably calcium ions acts by binding to
calmodulin and forming Ca-CaM, which subsequently
activates AC and GC.
 
Forskolin Elevates the Endogenous Levels of cAMP and cGMP
 
It is well-known that forskolin is a powerful activator of
AC. Indeed, application of 25 
 
 
 
M forskolin enhanced
the endogenous level of cAMP by ninefold (Fig. 3). Sur-
prisingly, forskolin also induced a strong increase in
cGMP concentration, by 3.5–4-fold (Fig. 3). Since forsko-
lin, via activated PKA, elevates [Ca
 
2
 
 
 
]
 
i
 
 in the discussed
system (Braiman et al., 1998), it is possible that the rise
in the cGMP level induced by forskolin is secondary to
this [Ca
 
2
 
 
 
]
 
i
 
 elevation. To examine this possibility, the
cells were exposed to 1 
 
 M thapsigargin inducing strong
Figure 2. Effect of Ca2  pathway blockage on the cGMP and
cAMP levels induced by ACh. Each group of bars represents the
maximal elevation in the intracellular level of cGMP (dark bars)
and cAMP (light bars) after stimulation with 10  M ACh in either
untreated cells (control) or in the cells treated with 150  M W-7,
low extracellular calcium concentration or 1  M thapsigargin. De-
pletion of intracellular calcium stores or inhibition of CaM im-
pedes the elevation in the cGMP and cAMP levels normally in-
duced by ACh. The changes in the levels of each nucleotide are
shown as a normalized increase relative to the levels of the same
nucleotide obtained in the presence of the blocker, before applica-
tion of ACh. Each bar represents an average over three to ﬁve ex-
periments with error bars representing the SEM.
Figure 3. Both cAMP and cGMP are elevated by forskolin. Each
group of bars represents the maximal elevation in the intracellular
level of cGMP (dark bars) and cAMP (light bars) after application
of 25  M forskolin. Elevation of intracellular calcium by 1  M
thapsigargin, moderately enhanced cGMP production. The effect
of 10  M ACh is shown for comparison. The changes in the levels
of each nucleotide are shown as a normalized increase relative to
the levels of the same nucleotide obtained before application of
the agents. Each bar represents an average over three to seven ex-
periments with error bars representing the SEM.333 Zagoory et al.
elevation of [Ca2 ]i (Braiman and Priel, 2001). It is im-
portant to emphasize that no apparent loss of viability
was detected in the ciliary cells and the cilia continued
beating vigorously for at least 2 h after application of
thapsigargin. As expected, high [Ca2 ]i induced a rise in
endogenous cGMP levels (Fig. 3). However, this rise was
considerably lower than the elevation in cGMP induced
by either forskolin or ACh (Fig. 3).
These results strongly suggest that [Ca2 ]i elevation
contributes to the increase in the cGMP levels, yet an
additional pathway exists for cGMP generation induced
by either ACh or forskolin. Since forskolin directly acti-
vates AC and consequently PKA, but not GC (Sunahara
et al., 1996; Denninger and Marletta, 1999), it is rea-
sonable to assume that one or more of the components
of the AC/PKA pathway stimulate GC, establishing a
cross talk with the GC/PKG pathway.
PKG Activity Is Essential for CBF Enhancement 
Induced by ACh
To evaluate the role of the cGMP-PKG pathway in the
process of CBF enhancement induced by ACh, two in-
hibitors were used: a GC inhibitor LY83583 (IC50   2
 M; Fleisch et al., 1984) and a PKG inhibitor KT5823
(IC50    0.234  M; Grider, 1993). The responses in
[Ca2 ]i and CBF to 10  M ACh were monitored simulta-
neously from the same cell, which was either untreated,
or pretreated with 50  M LY83583, or pretreated with
0.5  M KT5823. Addition of 10  M ACh to tissue cul-
tures pretreated with either the inhibitor of GC or the
inhibitor of PKG resulted in a partial attenuation of the
[Ca2 ]i rise (by  25 and 50%, respectively) and in a
complete inhibition of the CBF enhancement (Figs. 4
and 5). The decrease in the [Ca2 ]i rise produced by
the inhibitors is incomparable to their deleterious effect
on the CBF enhancement. Moreover, the results shown
below (see Figs. 6 and 7) and published elsewhere
(Korngreen and Priel, 1996; Levin et al., 1997) indicate
that a [Ca2 ]i rise of a similar magnitude can evoke a
strong CBF enhancement. The mechanism of the
cGMP/PKG involvement in the dynamic regulation of
[Ca2 ]i is not yet known, and is beyond the scope of this
work. Nevertheless, it is possible to conclude that PKG
activity is essential for CBF enhancement induced by
ACh, even in the presence of high [Ca2 ]i.
PKA Sustains the Second Phase of the CBF Response to ACh
To assess the role of PKA in stimulation of CBF by ACh,
we used two PKA inhibitors with two different modes of
action: H89 and Rp-8-Br-MB-cAMPS. H-89 is a protein
kinase inhibitor with a high speciﬁcity to PKA, which
interferes with the activity of the target enzyme by bind-
ing to its catalytic domain (Chijiwa et al., 1990). Rp-8-
Br-MB-cAMPS is a cell-permeable structural analogue
of cAMP that competes with the endogenous cAMP for
binding to the regulatory domain of PKA and, thereby,
prevents activation of the enzyme. This inhibitor is
highly speciﬁc for PKA and prefers PKA type I over
PKA type II (Gjertsen et al., 1995).
The responses in [Ca2 ]i and CBF to 10  M ACh
were monitored simultaneously from the same cell,
which was either untreated, or pretreated with 5  M
H-89, or pretreated with 100  M Rp-8-Br-MB-cAMPS.
Both inhibitors produced essentially identical effects.
The response to ACh of the cells pretreated with the
inhibitors was attenuated by 40–50% and signiﬁcantly
shortened (Figs. 6 and 7). The rise in [Ca2 ]i was di-
minished by 40–50% and followed by a relatively fast
decay (within 1–3 min after reaching the maximum)
to its basal level. The CBF enhancement was also at-
tenuated, and the degree of the attenuation was simi-
lar to the degree of inhibition in the [Ca2 ]i elevation.
Figure 4. Effect of GC blockage on the [Ca2 ]i and CBF en-
hancement induced by ACh. Representative experiments of re-
sponses in [Ca2 ]i (A) and CBF (B) to 10  M ACh obtained from
either untreated cells (A, dotted line; B, open circles) or from the
cells treated with 50  M LY-83583 (A, solid line; B, closed circles).
Inhibition of GC slightly attenuates the rise in [Ca2 ]i but com-
pletely abolishes the rise in CBF normally induced by ACh.334 Mechanism of Ciliary Stimulation by Acetylcholine
In addition, the second phase of the CBF enhance-
ment was completely abrogated, and CBF declined to
its basal level in a striking accordance with [Ca2 ]i
(Figs. 6 and 7).
According to the IC50 values of H-89 in mammalian
tissues (0.05  M for PKA and 0.5  M for PKG), this
blocker, used at 5  M, is expected to inhibit the PKG
activity as well. However, since the effect of H-89 (Figs.
6 and 7) was strikingly different from the effect of the
PKG and GC inhibitors (Figs. 4 and 5), and, at the
same time, it was virtually identical to the effect pro-
duced by the highly speciﬁc PKA inhibitor Rp-8-Br-
MB-cAMPS (Fig. 7), it is safe to assume that H-89 did
not inhibit PKG in our preparation. The discrepancy
may be a result of the differences in the enzyme sensi-
tivity or in the membrane permeability to H-89 be-
tween the mammalian and the frog tissue. These re-
sults suggest that PKA activity contributes to the dura-
tion and the magnitude of the ﬁrst phase and is
obligatory for the existence of the second phase of the
response to ACh.
DISCUSSION
Interplay between Ca2 , cGMP, and cAMP in the Process of 
CBF Enhancement
Over the last two decades, several works were published
which demonstrate that CBF can be enhanced by one
of the three ubiquitous second messengers: Ca2 ,
cGMP, or cAMP. In most studies, the role of each path-
way represented by these messengers was examined
and presented separately. Such an approach created an
impression that each of the second messengers repre-
sented an independent pathway for regulation of cili-
ary activity. In contrast to this view, this work demon-
strates that these pathways are closely interconnected,
and that their combined effect is required to achieve a
strong and sustained CBF enhancement.
We previously have shown that CBF enhancement in-
duced by ACh crucially relies on rise in [Ca2 ]i (Za-
goory et al., 2001). ACh achieves this effect by mobiliza-
tion of Ca2  from the intracellular stores. In this work,
we demonstrate that ACh also elevates the cytosolic lev-
Figure 5. Effect of the PKG
pathway blockage on the
[Ca2 ]i and CBF enhance-
ment induced by ACh. Repre-
sentative experiments of re-
sponses in [Ca2 ]i (A) and
CBF (B) to 10  M ACh ob-
tained from either untreated
cells (A, dotted line; B, open
circles) or from the cells
treated with 0.5  M KT-5823
(A, solid line; B, closed cir-
cles). C and D show [Ca2 ]i
elevation (C) and CBF en-
hancement (D) induced by
10   M ACh in either un-
treated cells or in the cells
pretreated with either 50  M
LY-83583 or 0.5  M KT-5823.
Each group of bars represents
the maximal increase (left
bar in the group) in [Ca2 ]i
or CBF, the increase obtained
5 min after reaching the max-
imum (middle bar in the
group), and the increase ob-
tained 10 min after reaching
the maximum (right bar in
the group). Inhibition of ei-
ther GC or PKG partially at-
tenuates the rise in [Ca2 ]i
but completely abolishes the
rise in CBF normally induced
by ACh. Each bar represents
an average over 10–19 experi-
ments with error bars repre-
senting the SEM.335 Zagoory et al.
els of cGMP and cAMP. It was shown that inhibition of
calmodulin abolishes the CBF enhancement induced
by ACh in the presence of high [Ca2 ]i (Zagoory et al.,
2001), conforming to the ﬁndings that calmodulin is
essential for the CBF enhancement normally induced
by ATP or by a calcium ionophore in the tissue cultures
from frog esophagus and from rabbit trachea (Braiman
et al., 2000b). These results indicate that calcium ions
themselves cannot enhance CBF. On the other hand, it
is well-known that Ca-CaM triggers a multitude of cellu-
lar events, including activation of GC and AC (Hinrich-
sen, 1993; Antoni, 1997; Stuehr, 1999; Chin and Means,
2000; Groves and Wang, 2000). Activated GC and AC
increase the intracellular levels of the correspondent
cyclic nucleotides cGMP and cAMP. Indeed, activation
of muscarinic receptors by ACh induced a strong, time-
dependent rise in the cytosolic levels of cGMP and
cAMP (Fig. 1). Moreover, the rise in the concentrations
of both nucleotides was strongly attenuated by pretreat-
ment of the cells with a calmodulin inhibitor or by im-
peding the [Ca2 ]i rise (Fig. 2). In addition, the time
course of the cGMP elevation closely resembles the re-
sponse in [Ca2 ]i induced by ACh (Figs. 1 and 4–7).
Taken together, these results indicate that the rise in
the cGMP level is mainly mediated by Ca-CaM.
The interplay between cAMP and Ca-CaM appears to
be more complex. Inhibition of CaM impedes the rise
in the cAMP level (Fig. 2), suggesting that the rise in
the cAMP level is also mediated by Ca-CaM. On the
other hand, the time course of the cAMP rise exhibits a
different behavior as compared with [Ca2 ]i (Figs. 1
and 4–7). The level of cAMP reaches its maximum in
10 min after stimulation and is maintained elevated for
a relatively long time after [Ca2 ]i decays to its basal
level. These results suggest that Ca-CaM is essential for
initiation of the rise in cAMP, probably via activation of
CaM-dependent AC. However, the ACh receptors uti-
lize an additional, Ca2 -independent pathway to main-
tain high levels of cAMP. It is tempting to suggest that
activation of the muscarinic receptors leads to inhibi-
tion of cAMP-speciﬁc phosphodiesterases, since prein-
cubation of the tissue with the phosphodiesterase in-
hibitor IBMX strongly inhibited the ability of ACh to
increase further the cAMP concentration (not shown).
Comparison between the time courses of the re-
sponse in cytosolic Ca2 , cGMP, and cAMP levels and
CBF (Figs. 1 and 4–7) demonstrates that during the ini-
tial strong CBF enhancement followed by a partial de-
cay, the concentrations of all three second messengers
are elevated. However, during the ﬁrst phase, the rise
in the concentrations of cytosolic Ca2  and cGMP are
more pronounced and highly correlated with the CBF
enhancement. On the other hand, the second phase of
the response (a sustained moderate enhancement of
CBF) seems to be an outcome of the elevation in the
cAMP concentration, probably via PKA activation.
The Role of PKG and PKA in the ACh-induced 
Ciliary Stimulation
Obviously, the rise in cGMP and cAMP concentrations
leads to activation of the correspondent kinases—PKG
and PKA. Indeed, inhibition of either PKG or GC abol-
ished completely the CBF enhancement induced by
ACh (Figs. 4 and 5). It is important to emphasize that
inhibition of either PKG or GC also attenuated the
[Ca2 ]i elevation induced by ACh. Therefore, one
might speculate that the abolishment of CBF enhance-
ment resulted from the attenuation in [Ca2 ] rise.
However, whereas the maximal rise in [Ca2 ]i induced
by ACh in the cells treated with either the PKA inhibi-
tors or the GC/PKG inhibitors were statistically indif-
ferent, a signiﬁcant enhancement in CBF was observed
Figure 6. Effect of the PKA pathway blockage on the [Ca2 ]i and
CBF enhancement induced by ACh. Representative experiments
of responses in [Ca2 ]i (A) and CBF (B) to 10  M ACh obtained
from either untreated cells (A, dotted line; B, open circles) or
from the cells treated with 5  M H-89 (A, solid line; B, closed cir-
cles). Inhibition of PKA attenuates the ﬁrst phase of the response
and completely abolishes the second phase of the response in both
[Ca2 ]i and CBF normally induced by ACh.336 Mechanism of Ciliary Stimulation by Acetylcholine
in the cells treated with the PKA inhibitors. Thus, the
partial attenuation in [Ca2 ] rise is unlikely to account
for the complete abolishment of CBF enhancement ob-
tained following GC/PKG inhibition. In addition, re-
sults published elsewhere (Korngreen and Priel, 1996;
Levin et al., 1997) also indicate that the [Ca2 ]i rise of a
similar magnitude or less can evoke a strong CBF en-
hancement. Therefore, abolishment of the CBF en-
hancement induced by the PKG or GC inhibitors is not
a result of a decrease in the [Ca2 ]i response.
Similar results were obtained using extracellular ATP
as an agonist in tissue cultures from frog esophagus or in
tissue cultures from rabbit trachea (Uzlaner and Priel,
1999; Braiman et al., 2001), suggesting the generality of
these ﬁndings. Furthermore, we previously have shown
that the AC-stimulating agent forskolin activates CBF in
a Ca2 -dependent and a Ca2 -independent manner
(Braiman et al., 1998). Both effects are mediated
through PKA. Yet, the PKG inhibitor KT5823 abolished
both modes of the forskolin-induced CBF enhancement
(unpublished data). These results indicate that PKG is a
universal key player in the process of ciliary stimulation.
The PKG activity is necessary for the CBF enhancement,
whether it is mediated through Ca2  or PKA. Elevation
in the cGMP concentration, observed after application
of forskolin (Fig. 3), further supports this idea.
Inhibition of PKA produced a profound change in
the time course of the CBF enhancement induced by
ACh (Figs. 6 and 7). The rise in CBF was transient, rap-
idly decaying to its basal level within 2–3 min after ap-
plication of ACh. The rise in [Ca2 ]i was also consider-
ably shortened and attenuated. Similar transient re-
sponse, accompanied by a high correlation between
CBF and [Ca2 ]i, was observed as a normal response to
ACh in tissue cultures from ovine trachea (Salathe et
al., 1997; Salathe and Bookman, 1999). It is tempting to
suggest that such a discrepancy may be due to either an
under activation of cAMP/PKA pathway in the tissue
culture used by Salathe et al. (1997) or over activation
of this pathway in our tissue culture.
It was shown that, in tissue cultures from frog esopha-
gus, PKA induced a release of Ca2  from the intracellu-
Figure 7. Effect of the PKA
pathway blockage on the
[Ca2 ]i and CBF enhance-
ment induced by ACh. Repre-
sentative experiments of re-
sponses in [Ca2 ]i (A) and
CBF (B) to 10  M ACh ob-
tained from either untreated
cells (A, dotted line; B, open
circles) or from the cells
treated with 100  M Rp-8-Br-
MB-cAMPS (A, solid line; B,
closed circles). C and D show
[Ca2 ]i elevation (C) and CBF
enhancement (D) induced by
10   M ACh in either un-
treated cells or in the cells pre-
treated with either 5  M H-89
or 100  M Rp-8-Br-MB-
cAMPS. Each group of bars
represents the maximal in-
crease (left bar in the group)
in [Ca2 ]i or CBF, the increase
obtained 5 min after reaching
the maximum (middle bar in
the group), and the increase
obtained 10 min after reach-
ing the maximum (right bar
in the group). Inhibition of
PKA attenuates the ﬁrst phase
of the response and com-
pletely abolishes the second
phase of the response in both
[Ca2 ]i and CBF normally in-
duced by ACh. Each bar rep-
resents an average over 8–20
experiments with error bars
representing the SEM.337 Zagoory et al.
lar stores (Braiman et al., 1998), most probably by phos-
phorylation of the IP3 receptor (Burgess et al., 1991).
Therefore, it is not surprising that inhibition of PKA
shortened and attenuated the rise in [Ca2 ]i induced by
ACh, which consequently led to the reduction of a com-
parable magnitude in the CBF enhancement during the
ﬁrst phase of the response. Apparently, PKA facilitates
Ca2  mobilization from the intracellular stores and,
thereby, prolongs and augments the ﬁrst, Ca2 -depen-
dent phase of the CBF enhancement.
We have shown that the rise in [Ca2 ]i is essential for
initiation, but not maintenance, of the second phase
of the CBF enhancement induced by ACh (Zagoory et
al., 2001). However, despite a signiﬁcant initial rise in
[Ca2 ]i, the second phase of the response did not de-
velop in the cells pretreated by the PKA blockers (Figs.
6 and 7). These results further support the conclusion
that PKA controls the second phase of the CBF en-
hancement induced by ACh, namely the sustained
moderately excited state of CBF. To support this idea
even further, it is worth mentioning that application of
forskolin to tissue cultures from frog esophagus also
produces a biphasic response in CBF with a second
phase being virtually identical to the one produced by
ACh (Braiman et al., 1998). In addition, we have
shown here that application of either ACh, or forsko-
lin or the calcium mobilizing agent thapsigargin lead
to an increase in the cGMP levels (Fig. 3). However,
the increase in cGMP induced by either ACh or forsko-
lin, which also profoundly increases the cAMP concen-
tration, is signiﬁcantly stronger than the increase in
cGMP induced by the calcium elevation alone. Appar-
ently, in addition to the ability of PKA to elevate the
cGMP concentration through Ca2  mobilization, an-
other mode exists for the cAMP pathway to stimulate
the cGMP pathway. The nature of this mode is yet to
be found.
Molecular Events Induced by ACh
Combining the results of this work with the results
published previously (Zagoory et al., 2001), we suggest
the following cascade of molecular events that under-
lies the biphasic CBF enhancement induced by ACh
(Fig. 8). Stimulation of muscarinic receptors by ACh
leads to activation of phospholipase C (PLC) and mo-
bilization of Ca2  from the intracellular stores. Eleva-
tion in [Ca2 ]i results in formation of Ca-CaM, which
activates GC and AC. The increased levels of cGMP
and cAMP activate the corresponding kinases, PKG
and PKA. The latter augments and prolongs the re-
sponse by facilitation of Ca2  release from the intracel-
lular stores. In addition, PKA or cAMP enhances the
elevation in cGMP by an unknown mechanism. The
concerted action of PKG, PKA, and elevated [Ca2 ]i re-
sults in a strong CBF enhancement (the ﬁrst phase).
At the same time, muscarinic receptors utilize an addi-
tional pathway to maintain a high level of cAMP, possi-
bly through inhibition of cAMP degradation. As a re-
sult, whereas the [Ca2 ]i gradually decreases, the
cAMP concentration and, consequently, the PKA activ-
ity remain high. The active PKA maintains a stable
moderately excited state of CBF in a Ca2 -independent
manner (the second phase). The unimpaired func-
tioning of PKG is required for this step to develop.
To conclude, in this work, we show that the Ca2 ,
cGMP, and cAMP signaling pathways are intimately in-
terconnected in the process of ciliary stimulation by
ACh. An unimpeded PKG activity is essential for the
CBF enhancement. The initial strong CBF enhance-
ment in response to ACh is mainly governed by PKG
and elevated [Ca2 ]i. The second phase of CBF en-
hancement induced by ACh, a stable moderately ele-
vated CBF, requires PKG activation but is mainly regu-
lated by PKA in a Ca2 -independent manner.
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